Repaglinide

Repaglinide is an oral anti-diabetic medication used to control high blood sugar levels in patients with Type 2 diabetes. It belongs to a class of drugs called meglitinides, which work by stimulating the release of insulin from the pancreas in response to meal intake. This helps lower blood glucose levels after eating.
Repaglinide is typically prescribed for patients who have difficulty controlling their blood sugar levels with diet, exercise, and weight management alone. It is not recommended for use in Type 1 diabetes or diabetic ketoacidosis.
The drug is available in tablet form and is usually taken before meals. Dosage is individualized based on blood glucose levels and the patient’s response to therapy. Follow the prescribed dosage and to monitor blood sugar levels regularly, as advised by the healthcare provider.
Common side effects of repaglinide may include hypoglycemia (low blood sugar), nausea, headache, and diarrhea. Hypoglycemia can be life-threatening if not treated promptly, so recognize its symptoms and to have a fast-acting source of sugar on hand.
Patients should inform their healthcare provider if they have any history of kidney or liver disease, as repaglinide may interact with these conditions. Pregnant or breastfeeding women should consult their physician before using this medication.